This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Jun:7 Suppl 1:43-7.

doi: 10.1097/00004850-199206001-00012.

Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder

N A Fineberg¹, T Bullock, D B Montgomery, S A Montgomery

Affiliations

PMID: 1517558
DOI: 10.1097/00004850-199206001-00012

Review

Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder

N A Fineberg et al. Int Clin Psychopharmacol. 1992 Jun.

. 1992 Jun:7 Suppl 1:43-7.

doi: 10.1097/00004850-199206001-00012.

Authors

N A Fineberg¹, T Bullock, D B Montgomery, S A Montgomery

Affiliation

¹ Academic Department of Psychiatry, St Mary's Hospital Medical School, London, UK.

PMID: 1517558
DOI: 10.1097/00004850-199206001-00012

No abstract available

PubMed Disclaimer

Similar articles

Selective serotonin reuptake inhibitors in OCD.
Montgomery SA, Bullock T, Fineberg N, Montgomery D. Montgomery SA, et al. Clin Neuropharmacol. 1992;15 Suppl 1 Pt A:255A-256A. doi: 10.1097/00002826-199201001-00133. Clin Neuropharmacol. 1992. PMID: 1498831 No abstract available.
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Jenike MA, Hyman S, Baer L, Holland A, Minichiello WE, Buttolph L, Summergrad P, Seymour R, Ricciardi J. Jenike MA, et al. Am J Psychiatry. 1990 Sep;147(9):1209-15. doi: 10.1176/ajp.147.9.1209. Am J Psychiatry. 1990. PMID: 2143637 Clinical Trial.
Pharmacotherapy of obsessive compulsive disorder.
Goodman WK, McDougle CJ, Price LH. Goodman WK, et al. J Clin Psychiatry. 1992 Apr;53 Suppl:29-37. J Clin Psychiatry. 1992. PMID: 1532962 Review.
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Barr LC, Goodman WK, Anand A, McDougle CJ, Price LH. Barr LC, et al. Am J Psychiatry. 1997 Sep;154(9):1293-5. doi: 10.1176/ajp.154.9.1293. Am J Psychiatry. 1997. PMID: 9286191 Clinical Trial.
Pharmacology of sertraline: a review.
Heym J, Koe BK. Heym J, et al. J Clin Psychiatry. 1988 Aug;49 Suppl:40-5. J Clin Psychiatry. 1988. PMID: 3045112 Review.

See all similar articles

Cited by

Obsessive-complusive disorder: pharmacological treatment.
Thomsen PH. Thomsen PH. Eur Child Adolesc Psychiatry. 2000;9 Suppl 1:I76-84. doi: 10.1007/s007870070021. Eur Child Adolesc Psychiatry. 2000. PMID: 11140782 Review.
Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice.
Klenotich SJ, Seiglie MP, McMurray MS, Roitman JD, Le Grange D, Dugad P, Dulawa SC. Klenotich SJ, et al. Neuropsychopharmacology. 2012 Jun;37(7):1620-31. doi: 10.1038/npp.2012.7. Epub 2012 Mar 7. Neuropsychopharmacology. 2012. PMID: 22395732 Free PMC article.
Treatment of obsessive-compulsive disorder in children and adolescents. A review of the literature.
Thomsen PH. Thomsen PH. Eur Child Adolesc Psychiatry. 1996 Jun;5(2):55-66. doi: 10.1007/BF01989497. Eur Child Adolesc Psychiatry. 1996. PMID: 8814411 Review.
A novel potential therapeutic avenue for autism: design, synthesis and pharmacophore generation of SSRIs with dual action.
Ghoneim OM, Ibrahim DA, El-Deeb IM, Lee SH, Booth RG. Ghoneim OM, et al. Bioorg Med Chem Lett. 2011 Nov 15;21(22):6714-23. doi: 10.1016/j.bmcl.2011.09.046. Epub 2011 Sep 21. Bioorg Med Chem Lett. 2011. PMID: 21982496 Free PMC article.
Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms.
Collins HM. Collins HM. Int J Neuropsychopharmacol. 2024 Dec 1;27(12):pyae057. doi: 10.1093/ijnp/pyae057. Int J Neuropsychopharmacol. 2024. PMID: 39611453 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information